United Kingdom · Life Sciences Lvl3
Siftr Bio Ltd
Siftr Bio Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Jul 2026.
Announcements
Innovate UK funding awarded
£439,387 · Investment Accelerator grant; “A programmable linker platform to maximise the therapeutic index of antibody-drug conjugat”; London
Innovate UK funding awarded
£432,102 · Collaborative R&D grant; “Non-internalising antibody-drug conjugates for heterogenous colorectal cancers”; London
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.